SIFI > International Markets
International Markets
In the last years SIFI has undergone a virtuous growth of its business, evolving into an industrial group of companies, consolidating domestic leadership and expanding into international markets.

Internationalization for SIFI Group means exporting a brand that is synonymous with specialization and tradition in ophthalmology, quality and innovation, ethics and professionalism, scientific education and proximity to physicians and patients, high medical and technological contents and commitment to social responsibility.

SIFI group has acquired a strong presence in the Americas and in European countries, either through its own subsidiaries or through partnering commercial distributors.

Currently the global key markets include Mexico, Romania, Spain, UK, Russia and Turkey where SIFI already has a significant presence through exclusive distributors.

Direct subsidiaries are present in Mexico (Laboratorios SIFI de México S.A. de C.V.) and Romania (Oftafarma srl).

share & tag us with
#EyeCare #eyeinfo #health #innovation #business #eye #vision #leadership #pharma
#Development
“Vision is the art of seeing what is invisible to others.”
Jonathan Swift

 
 
Disclosure of Transfers of value    SIFI is a pharmaceutical company committed to fulfilling the needs of its customers, both patients and ophthalmologists.   SIFI strongly...
 
Vision & History Established in 1935 by two local pharmacists in Sicily, SIFI started as a venture, specializing in the preparation of ophthalmic products. Since then, research, development,...
 
General questions info@sifigroup.com   Products Quality QualityUnit@sifigroup.com       Pharmacovigilance pharmacovigilance@sifigroup.com   Vigilance...

On our Social Channels

From our News Center

SIFI announces an important development in the innovative SoundMedsTM service, dedicated to patients with difficulty in reading product information leaflets. The audio service, which allows users...
 

 

13 October

One step closer to the European registration of a safe and effective drug for the treatment of Acanthamoeba Keratitis. SIFI is pleased to announce that AIFA (Italian Medicines...
Follow Us!